

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 6.15436766 |
| 2 | positive regulation of chemokine biosynthetic process (GO:0045080) | 6.14683933 |
| 3 | response to peptidoglycan (GO:0032494) | 6.11981670 |
| 4 | positive regulation of heat generation (GO:0031652) | 6.11893301 |
| 5 | regulation of fever generation (GO:0031620) | 5.99956833 |
| 6 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 5.48140511 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.39727821 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.39727821 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 5.39727821 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 5.39727821 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 5.39727821 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.39727821 |
| 13 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 5.37329596 |
| 14 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 5.09670332 |
| 15 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 5.09670332 |
| 16 | regulation of activation of Janus kinase activity (GO:0010533) | 5.05251624 |
| 17 | regulation of chemokine biosynthetic process (GO:0045073) | 5.04616856 |
| 18 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 5.00667629 |
| 19 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.95488751 |
| 20 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.71471802 |
| 21 | regulation of heat generation (GO:0031650) | 4.69108718 |
| 22 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.61471697 |
| 23 | cellular response to exogenous dsRNA (GO:0071360) | 4.48032556 |
| 24 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 4.44589653 |
| 25 | negative regulation of cytokine production involved in immune response (GO:0002719) | 4.40697110 |
| 26 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.33399753 |
| 27 | natural killer cell activation involved in immune response (GO:0002323) | 4.32441581 |
| 28 | neutrophil activation involved in immune response (GO:0002283) | 4.31722593 |
| 29 | negative regulation of amino acid transport (GO:0051956) | 4.31281460 |
| 30 | eosinophil chemotaxis (GO:0048245) | 4.23080336 |
| 31 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 4.18425958 |
| 32 | cellular response to interferon-beta (GO:0035458) | 4.16283165 |
| 33 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.12959894 |
| 34 | regulation of chronic inflammatory response (GO:0002676) | 4.00190806 |
| 35 | regulation of podosome assembly (GO:0071801) | 3.99171112 |
| 36 | regulation of mononuclear cell migration (GO:0071675) | 3.98288220 |
| 37 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.98229037 |
| 38 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.95136147 |
| 39 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.92480668 |
| 40 | superoxide anion generation (GO:0042554) | 3.91865660 |
| 41 | regulation of memory T cell differentiation (GO:0043380) | 3.90671406 |
| 42 | oligosaccharide catabolic process (GO:0009313) | 3.90071317 |
| 43 | response to muramyl dipeptide (GO:0032495) | 3.86725836 |
| 44 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.85952619 |
| 45 | eosinophil migration (GO:0072677) | 3.85625509 |
| 46 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.84971700 |
| 47 | activation of MAPKKK activity (GO:0000185) | 3.84488417 |
| 48 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.80256954 |
| 49 | positive regulation of interferon-alpha production (GO:0032727) | 3.78626753 |
| 50 | response to protozoan (GO:0001562) | 3.77890010 |
| 51 | regulation of immunoglobulin secretion (GO:0051023) | 3.77440335 |
| 52 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.77211143 |
| 53 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.76471081 |
| 54 | macrophage activation involved in immune response (GO:0002281) | 3.75163634 |
| 55 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.73717843 |
| 56 | granulocyte activation (GO:0036230) | 3.72556204 |
| 57 | response to interferon-beta (GO:0035456) | 3.72090697 |
| 58 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.72033059 |
| 59 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.71927406 |
| 60 | regulation of interferon-alpha production (GO:0032647) | 3.71113383 |
| 61 | regulation of vitamin metabolic process (GO:0030656) | 3.64788748 |
| 62 | positive regulation of interleukin-17 production (GO:0032740) | 3.64271945 |
| 63 | regulation of interleukin-17 production (GO:0032660) | 3.63583720 |
| 64 | negative regulation of viral genome replication (GO:0045071) | 3.58837663 |
| 65 | positive regulation of mast cell degranulation (GO:0043306) | 3.57717888 |
| 66 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.57717888 |
| 67 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.55220429 |
| 68 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 3.54896542 |
| 69 | negative regulation by host of viral transcription (GO:0043922) | 3.52865967 |
| 70 | detection of molecule of bacterial origin (GO:0032490) | 3.52782988 |
| 71 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.51363658 |
| 72 | response to host immune response (GO:0052572) | 3.51363658 |
| 73 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.48219328 |
| 74 | regulation of T-helper 1 type immune response (GO:0002825) | 3.47436354 |
| 75 | respiratory burst (GO:0045730) | 3.46225576 |
| 76 | positive regulation of lymphocyte migration (GO:2000403) | 3.45165509 |
| 77 | positive regulation of humoral immune response (GO:0002922) | 3.44548261 |
| 78 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.43152903 |
| 79 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.41731024 |
| 80 | negative regulation of interleukin-17 production (GO:0032700) | 3.38937882 |
| 81 | negative regulation of T cell mediated immunity (GO:0002710) | 3.38472555 |
| 82 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.37814493 |
| 83 | positive regulation of interleukin-12 production (GO:0032735) | 3.36265771 |
| 84 | monocyte chemotaxis (GO:0002548) | 3.35607071 |
| 85 | positive regulation of interleukin-10 production (GO:0032733) | 3.34388947 |
| 86 | glycosphingolipid catabolic process (GO:0046479) | 3.33809982 |
| 87 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.33736842 |
| 88 | cellular response to lipopolysaccharide (GO:0071222) | 3.30606279 |
| 89 | leukocyte aggregation (GO:0070486) | 3.30361020 |
| 90 | positive regulation of interleukin-6 production (GO:0032755) | 3.29654892 |
| 91 | regulation of T-helper cell differentiation (GO:0045622) | 3.29645993 |
| 92 | negative regulation of type 2 immune response (GO:0002829) | 3.27777985 |
| 93 | lymphocyte chemotaxis (GO:0048247) | 3.27591937 |
| 94 | reactive oxygen species biosynthetic process (GO:1903409) | 3.27139209 |
| 95 | regulation of vascular endothelial growth factor production (GO:0010574) | 3.27104463 |
| 96 | cellular response to nicotine (GO:0071316) | 3.26246019 |
| 97 | T cell migration (GO:0072678) | 3.25392329 |
| 98 | defense response to protozoan (GO:0042832) | 3.24327429 |
| 99 | positive regulation of tumor necrosis factor production (GO:0032760) | 3.23749670 |
| 100 | positive regulation of chemokine production (GO:0032722) | 3.23169944 |
| 101 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 3.23003949 |
| 102 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.22695318 |
| 103 | negative regulation of interleukin-12 production (GO:0032695) | 3.22504055 |
| 104 | NIK/NF-kappaB signaling (GO:0038061) | 3.22105473 |
| 105 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.21854404 |
| 106 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.21692305 |
| 107 | regulation of mast cell degranulation (GO:0043304) | 3.21159145 |
| 108 | glycolipid catabolic process (GO:0019377) | 3.20944005 |
| 109 | neutrophil chemotaxis (GO:0030593) | 3.19376248 |
| 110 | chronic inflammatory response (GO:0002544) | 3.18729400 |
| 111 | regulation of NF-kappaB import into nucleus (GO:0042345) | 3.17657880 |
| 112 | cellular response to molecule of bacterial origin (GO:0071219) | 3.15842475 |
| 113 | germinal center formation (GO:0002467) | 3.15524109 |
| 114 | regulation of T cell cytokine production (GO:0002724) | 3.14855027 |
| 115 | cellular extravasation (GO:0045123) | 3.14685317 |
| 116 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.14270861 |
| 117 | negative regulation of lipid storage (GO:0010888) | 3.13762272 |
| 118 | positive regulation of acute inflammatory response (GO:0002675) | 3.13296614 |
| 119 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.13137545 |
| 120 | T-helper 1 type immune response (GO:0042088) | 3.12730364 |
| 121 | positive regulation of p38MAPK cascade (GO:1900745) | 3.10200777 |
| 122 | positive regulation of type 2 immune response (GO:0002830) | 3.05912509 |
| 123 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.86670675 |
| 124 | adhesion of symbiont to host cell (GO:0044650) | 2.85208836 |
| 125 | virion attachment to host cell (GO:0019062) | 2.85208836 |
| 126 | regulation of interleukin-6 production (GO:0032675) | 2.83654715 |
| 127 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.78349570 |
| 128 | regulation of growth of symbiont in host (GO:0044126) | 2.78349570 |
| 129 | negative regulation of growth of symbiont in host (GO:0044130) | 2.78349570 |
| 130 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.78349570 |
| 131 | positive regulation of prostaglandin secretion (GO:0032308) | 2.77178951 |
| 132 | neutrophil migration (GO:1990266) | 2.77174652 |
| 133 | cellular response to arsenic-containing substance (GO:0071243) | 2.76548645 |
| 134 | negative regulation of cytokine secretion (GO:0050710) | 2.76313965 |
| 135 | ovulation (GO:0030728) | 2.75752438 |
| 136 | regulation of prostaglandin secretion (GO:0032306) | 2.74996185 |
| 137 | cellular response to biotic stimulus (GO:0071216) | 2.74361018 |
| 138 | immunoglobulin mediated immune response (GO:0016064) | 2.74144318 |
| 139 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.70218023 |
| 140 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.69742357 |
| 141 | macrophage chemotaxis (GO:0048246) | 2.67901277 |
| 142 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.67750227 |
| 143 | acute-phase response (GO:0006953) | 2.66585026 |
| 144 | ceramide catabolic process (GO:0046514) | 2.65815494 |
| 145 | myeloid dendritic cell differentiation (GO:0043011) | 2.60597054 |
| 146 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.59477276 |
| 147 | granulocyte chemotaxis (GO:0071621) | 2.59304178 |
| 148 | regulation of lipid storage (GO:0010883) | 2.56107994 |
| 149 | regulation of type 2 immune response (GO:0002828) | 2.55800055 |
| 150 | response to manganese ion (GO:0010042) | 2.55731059 |
| 151 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.55019138 |
| 152 | membrane lipid catabolic process (GO:0046466) | 2.54274909 |
| 153 | type I interferon signaling pathway (GO:0060337) | 2.51072605 |
| 154 | cellular response to type I interferon (GO:0071357) | 2.51072605 |
| 155 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.51025887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.58414221 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.64135767 |
| 3 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.00744483 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.00402672 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.87903685 |
| 6 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.86961668 |
| 7 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.78891238 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.46415904 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.30245490 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.83711567 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.82141893 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.70178210 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.65816586 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.44178594 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.21422364 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.10656599 |
| 17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.08082085 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.02349789 |
| 19 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.00825221 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 10.7864772 |
| 21 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.99907034 |
| 22 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.96370709 |
| 23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.91074711 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.87813669 |
| 25 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.85851886 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.77713223 |
| 27 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.73138592 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.62052104 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.59276232 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.58647123 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57514095 |
| 32 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.55891811 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.53634864 |
| 34 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.53221491 |
| 35 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.50266037 |
| 36 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.47840133 |
| 37 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.42440031 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40069421 |
| 39 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.39223523 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.38661246 |
| 41 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.37822429 |
| 42 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.36103835 |
| 43 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.36103835 |
| 44 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.36103835 |
| 45 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29763334 |
| 46 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.26840689 |
| 47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23026079 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.22272285 |
| 49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.21581754 |
| 50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19705096 |
| 51 | MYB_26560356_Chip-Seq_TH2_Human | 1.19314386 |
| 52 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18805687 |
| 53 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.18171878 |
| 54 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.15310027 |
| 55 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14667314 |
| 56 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.14053800 |
| 57 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.13057039 |
| 58 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.11835954 |
| 59 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10756523 |
| 60 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09669821 |
| 61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.08466071 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.06831507 |
| 63 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06196203 |
| 64 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.06046367 |
| 65 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05161246 |
| 66 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03688355 |
| 67 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.03240437 |
| 68 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02514409 |
| 69 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02348355 |
| 70 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.02287403 |
| 71 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.01998127 |
| 72 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.01998127 |
| 73 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.99819024 |
| 74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99290801 |
| 75 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.97187794 |
| 76 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.95972036 |
| 77 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94756417 |
| 78 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93526764 |
| 79 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.91783684 |
| 80 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.91296237 |
| 81 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.91074059 |
| 82 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.90486024 |
| 83 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90062787 |
| 84 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89787018 |
| 85 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.88792627 |
| 86 | MAF_26560356_Chip-Seq_TH1_Human | 0.87134151 |
| 87 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.85769678 |
| 88 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.85018271 |
| 89 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84182408 |
| 90 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.83533731 |
| 91 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.83064943 |
| 92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81959929 |
| 93 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81804560 |
| 94 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81508429 |
| 95 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81396952 |
| 96 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.80059335 |
| 97 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.79905162 |
| 98 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.79555237 |
| 99 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.77705956 |
| 100 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.76197148 |
| 101 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.76197148 |
| 102 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74791789 |
| 103 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.73630993 |
| 104 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.73471480 |
| 105 | MYB_26560356_Chip-Seq_TH1_Human | 0.73436581 |
| 106 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.72690876 |
| 107 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.71269304 |
| 108 | UTX_26944678_Chip-Seq_JUKART_Human | 0.69571892 |
| 109 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68538529 |
| 110 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.66452389 |
| 111 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.66194956 |
| 112 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.64846347 |
| 113 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.64198844 |
| 114 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.63678573 |
| 115 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.62425147 |
| 116 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.61820571 |
| 117 | TP53_16413492_ChIP-PET_HCT116_Human | 0.61354496 |
| 118 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.60914615 |
| 119 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.60863335 |
| 120 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.60659770 |
| 121 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.59627257 |
| 122 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.58915607 |
| 123 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.58634763 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006082_CNS_inflammation | 5.74155735 |
| 2 | MP0009785_altered_susceptibility_to | 4.81351672 |
| 3 | MP0003436_decreased_susceptibility_to | 4.31625339 |
| 4 | MP0003724_increased_susceptibility_to | 4.17077129 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.92719270 |
| 6 | MP0003303_peritoneal_inflammation | 3.87860920 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.54855951 |
| 8 | MP0002419_abnormal_innate_immunity | 3.43258585 |
| 9 | MP0001835_abnormal_antigen_presentation | 3.28882175 |
| 10 | MP0002139_abnormal_hepatobiliary_system | 3.17897517 |
| 11 | MP0005025_abnormal_response_to | 3.15510924 |
| 12 | MP0009764_decreased_sensitivity_to | 2.71723844 |
| 13 | MP0004947_skin_inflammation | 2.45142892 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.42994005 |
| 15 | MP0002723_abnormal_immune_serum | 2.42169466 |
| 16 | MP0001533_abnormal_skeleton_physiology | 2.35901684 |
| 17 | MP0009278_abnormal_bone_marrow | 2.31399332 |
| 18 | MP0002006_tumorigenesis | 2.26964747 |
| 19 | MP0001800_abnormal_humoral_immune | 2.26116635 |
| 20 | MP0004510_myositis | 2.18581185 |
| 21 | MP0005671_abnormal_response_to | 2.17864340 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.10873004 |
| 23 | MP0005387_immune_system_phenotype | 2.03041077 |
| 24 | MP0001790_abnormal_immune_system | 2.03041077 |
| 25 | MP0003075_altered_response_to | 2.00921024 |
| 26 | MP0001819_abnormal_immune_cell | 1.95952436 |
| 27 | MP0002420_abnormal_adaptive_immunity | 1.94137534 |
| 28 | MP0003690_abnormal_glial_cell | 1.93887891 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.92627757 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.89770727 |
| 31 | MP0008469_abnormal_protein_level | 1.89686975 |
| 32 | MP0003806_abnormal_nucleotide_metabolis | 1.82560379 |
| 33 | MP0006054_spinal_hemorrhage | 1.81453009 |
| 34 | MP0003448_altered_tumor_morphology | 1.80189773 |
| 35 | MP0000343_altered_response_to | 1.78230030 |
| 36 | MP0008004_abnormal_stomach_pH | 1.76135607 |
| 37 | MP0000685_abnormal_immune_system | 1.72729110 |
| 38 | MP0001853_heart_inflammation | 1.68899883 |
| 39 | MP0002405_respiratory_system_inflammati | 1.67183329 |
| 40 | MP0003828_pulmonary_edema | 1.66732172 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.63764334 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.57852381 |
| 43 | MP0005166_decreased_susceptibility_to | 1.54379225 |
| 44 | MP0005167_abnormal_blood-brain_barrier | 1.53712443 |
| 45 | MP0000858_altered_metastatic_potential | 1.51925952 |
| 46 | MP0005164_abnormal_response_to | 1.51059345 |
| 47 | MP0003453_abnormal_keratinocyte_physiol | 1.46223719 |
| 48 | MP0002998_abnormal_bone_remodeling | 1.34171434 |
| 49 | MP0002254_reproductive_system_inflammat | 1.27612719 |
| 50 | MP0000716_abnormal_immune_system | 1.24775156 |
| 51 | MP0002332_abnormal_exercise_endurance | 1.22574421 |
| 52 | MP0003172_abnormal_lysosome_physiology | 1.22152116 |
| 53 | MP0003195_calcinosis | 1.18874672 |
| 54 | MP0003950_abnormal_plasma_membrane | 1.17766859 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.17394198 |
| 56 | MP0001545_abnormal_hematopoietic_system | 1.17394198 |
| 57 | MP0002933_joint_inflammation | 1.16820265 |
| 58 | MP0000465_gastrointestinal_hemorrhage | 1.15304533 |
| 59 | MP0010352_gastrointestinal_tract_polyps | 1.14743774 |
| 60 | MP0005390_skeleton_phenotype | 1.14528236 |
| 61 | MP0001501_abnormal_sleep_pattern | 1.13682091 |
| 62 | MP0005076_abnormal_cell_differentiation | 1.13166807 |
| 63 | MP0000604_amyloidosis | 1.12552974 |
| 64 | MP0002398_abnormal_bone_marrow | 1.10177528 |
| 65 | MP0009840_abnormal_foam_cell | 1.09262953 |
| 66 | MP0001542_abnormal_bone_strength | 1.06478814 |
| 67 | MP0009763_increased_sensitivity_to | 1.03347053 |
| 68 | MP0005310_abnormal_salivary_gland | 1.02471396 |
| 69 | MP0003191_abnormal_cellular_cholesterol | 1.00498360 |
| 70 | MP0003656_abnormal_erythrocyte_physiolo | 0.99070931 |
| 71 | MP0001851_eye_inflammation | 0.97811925 |
| 72 | MP0002429_abnormal_blood_cell | 0.96556224 |
| 73 | MP0002277_abnormal_respiratory_mucosa | 0.94413311 |
| 74 | MP0004883_abnormal_blood_vessel | 0.93422002 |
| 75 | MP0002138_abnormal_hepatobiliary_system | 0.93183457 |
| 76 | MP0000689_abnormal_spleen_morphology | 0.92577294 |
| 77 | MP0004808_abnormal_hematopoietic_stem | 0.92482186 |
| 78 | MP0009765_abnormal_xenobiotic_induced | 0.90710369 |
| 79 | MP0005647_abnormal_sex_gland | 0.90144286 |
| 80 | MP0003186_abnormal_redox_activity | 0.88451786 |
| 81 | MP0003300_gastrointestinal_ulcer | 0.87869553 |
| 82 | MP0005595_abnormal_vascular_smooth | 0.86801014 |
| 83 | MP0000920_abnormal_myelination | 0.85852482 |
| 84 | MP0005623_abnormal_meninges_morphology | 0.83749549 |
| 85 | MP0005535_abnormal_body_temperature | 0.83241599 |
| 86 | MP0002722_abnormal_immune_system | 0.80826783 |
| 87 | MP0000249_abnormal_blood_vessel | 0.76614376 |
| 88 | MP0003646_muscle_fatigue | 0.67865071 |
| 89 | MP0005266_abnormal_metabolism | 0.67659277 |
| 90 | MP0008260_abnormal_autophagy | 0.64688704 |
| 91 | MP0005165_increased_susceptibility_to | 0.64320539 |
| 92 | MP0001727_abnormal_embryo_implantation | 0.62757144 |
| 93 | MP0003795_abnormal_bone_structure | 0.61758738 |
| 94 | MP0001764_abnormal_homeostasis | 0.61286653 |
| 95 | MP0008875_abnormal_xenobiotic_pharmacok | 0.60932512 |
| 96 | MP0004858_abnormal_nervous_system | 0.60367438 |
| 97 | MP0000569_abnormal_digit_pigmentation | 0.59599060 |
| 98 | MP0005365_abnormal_bile_salt | 0.58694855 |
| 99 | MP0003183_abnormal_peptide_metabolism | 0.58458236 |
| 100 | MP0002837_dystrophic_cardiac_calcinosis | 0.57375258 |
| 101 | MP0005376_homeostasis/metabolism_phenot | 0.57037509 |
| 102 | MP0002136_abnormal_kidney_physiology | 0.56092883 |
| 103 | MP0003329_amyloid_beta_deposits | 0.55357802 |
| 104 | MP0003045_fibrosis | 0.54711171 |
| 105 | MP0005023_abnormal_wound_healing | 0.53688566 |
| 106 | MP0008873_increased_physiological_sensi | 0.52158500 |
| 107 | MP0000371_diluted_coat_color | 0.51378623 |
| 108 | MP0001663_abnormal_digestive_system | 0.50026373 |
| 109 | MP0002693_abnormal_pancreas_physiology | 0.47661587 |
| 110 | MP0003091_abnormal_cell_migration | 0.45782089 |
| 111 | MP0004782_abnormal_surfactant_physiolog | 0.45300716 |
| 112 | MP0008874_decreased_physiological_sensi | 0.44148129 |
| 113 | MP0005451_abnormal_body_composition | 0.43212101 |
| 114 | MP0000609_abnormal_liver_physiology | 0.42372025 |
| 115 | MP0002168_other_aberrant_phenotype | 0.41404631 |
| 116 | MP0001958_emphysema | 0.39611509 |
| 117 | MP0002295_abnormal_pulmonary_circulatio | 0.39429384 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.59135336 |
| 2 | Eczematoid dermatitis (HP:0000976) | 7.15192883 |
| 3 | Stomatitis (HP:0010280) | 7.10262191 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 6.90274487 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.86939710 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.10328902 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 5.95149465 |
| 8 | Optic neuritis (HP:0100653) | 5.95149465 |
| 9 | Orchitis (HP:0100796) | 5.81021609 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 5.73622669 |
| 11 | Abnormality of macrophages (HP:0004311) | 5.43603324 |
| 12 | Myositis (HP:0100614) | 5.35660870 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 4.67199781 |
| 14 | Interstitial pulmonary disease (HP:0006530) | 4.37854223 |
| 15 | Gingivitis (HP:0000230) | 4.28401223 |
| 16 | Loss of speech (HP:0002371) | 4.20931968 |
| 17 | Recurrent skin infections (HP:0001581) | 4.09223741 |
| 18 | Obstructive lung disease (HP:0006536) | 4.07975049 |
| 19 | Chronic obstructive pulmonary disease (HP:0006510) | 4.07975049 |
| 20 | Nausea (HP:0002018) | 4.03791514 |
| 21 | Autoimmune thrombocytopenia (HP:0001973) | 3.87466511 |
| 22 | Nuclear cataract (HP:0100018) | 3.78838230 |
| 23 | Vasculitis (HP:0002633) | 3.77249503 |
| 24 | Increased cerebral lipofuscin (HP:0011813) | 3.70361554 |
| 25 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.70280729 |
| 26 | Neurofibrillary tangles (HP:0002185) | 3.70225677 |
| 27 | Axonal loss (HP:0003447) | 3.63493267 |
| 28 | Keratoconjunctivitis sicca (HP:0001097) | 3.51701573 |
| 29 | Pulmonary infiltrates (HP:0002113) | 3.51652934 |
| 30 | Mutism (HP:0002300) | 3.51312811 |
| 31 | Complement deficiency (HP:0004431) | 3.47346010 |
| 32 | Recurrent fungal infections (HP:0002841) | 3.43648780 |
| 33 | Vacuolated lymphocytes (HP:0001922) | 3.40926147 |
| 34 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.22596822 |
| 35 | Keratoconjunctivitis (HP:0001096) | 3.20468744 |
| 36 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.20082260 |
| 37 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.20082260 |
| 38 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.20082260 |
| 39 | Urticaria (HP:0001025) | 3.10224187 |
| 40 | Mucopolysacchariduria (HP:0008155) | 3.03083702 |
| 41 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.03083702 |
| 42 | Basal ganglia calcification (HP:0002135) | 2.96417254 |
| 43 | Abnormality of complement system (HP:0005339) | 2.87279175 |
| 44 | Disinhibition (HP:0000734) | 2.81631788 |
| 45 | Apathy (HP:0000741) | 2.81441872 |
| 46 | Tetraparesis (HP:0002273) | 2.80641180 |
| 47 | Thick nail (HP:0001805) | 2.79742502 |
| 48 | Periodontitis (HP:0000704) | 2.78440422 |
| 49 | Abnormality of the pericardium (HP:0001697) | 2.75923825 |
| 50 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.75113600 |
| 51 | Prostate neoplasm (HP:0100787) | 2.74537501 |
| 52 | Arterial thrombosis (HP:0004420) | 2.72903922 |
| 53 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.72662691 |
| 54 | Diminished motivation (HP:0000745) | 2.72320855 |
| 55 | Fused cervical vertebrae (HP:0002949) | 2.70056050 |
| 56 | Cellulitis (HP:0100658) | 2.69724176 |
| 57 | Pustule (HP:0200039) | 2.69198999 |
| 58 | Abnormality of iron homeostasis (HP:0011031) | 2.67521627 |
| 59 | Meningitis (HP:0001287) | 2.66287712 |
| 60 | Recurrent viral infections (HP:0004429) | 2.60658204 |
| 61 | Petechiae (HP:0000967) | 2.59353518 |
| 62 | Recurrent cutaneous fungal infections (HP:0011370) | 2.51288779 |
| 63 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.51288779 |
| 64 | Leukocytosis (HP:0001974) | 2.49230943 |
| 65 | Cerebral inclusion bodies (HP:0100314) | 2.48384400 |
| 66 | Hemoptysis (HP:0002105) | 2.48219978 |
| 67 | Abnormality of the pleura (HP:0002103) | 2.46493259 |
| 68 | Progressive neurologic deterioration (HP:0002344) | 2.42713524 |
| 69 | Purpura (HP:0000979) | 2.42240026 |
| 70 | Amyloidosis (HP:0011034) | 2.41803162 |
| 71 | Anorexia (HP:0002039) | 2.40622818 |
| 72 | Poor head control (HP:0002421) | 2.40196024 |
| 73 | Joint swelling (HP:0001386) | 2.38874386 |
| 74 | Autoimmune hemolytic anemia (HP:0001890) | 2.37740345 |
| 75 | Metaphyseal irregularity (HP:0003025) | 2.32107172 |
| 76 | Recurrent pneumonia (HP:0006532) | 2.30774680 |
| 77 | Parakeratosis (HP:0001036) | 2.30180727 |
| 78 | Myocardial infarction (HP:0001658) | 2.30090712 |
| 79 | Joint hemorrhage (HP:0005261) | 2.29544941 |
| 80 | Agnosia (HP:0010524) | 2.29440721 |
| 81 | Glomerulonephritis (HP:0000099) | 2.28887844 |
| 82 | Inappropriate behavior (HP:0000719) | 2.28731354 |
| 83 | Neuronal loss in central nervous system (HP:0002529) | 2.23329795 |
| 84 | Nephritis (HP:0000123) | 2.23071582 |
| 85 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.22779710 |
| 86 | Hemorrhage of the eye (HP:0011885) | 2.22582450 |
| 87 | Increased IgM level (HP:0003496) | 2.22173322 |
| 88 | Increased IgE level (HP:0003212) | 2.21511078 |
| 89 | Hepatosplenomegaly (HP:0001433) | 2.20680407 |
| 90 | Bone pain (HP:0002653) | 2.20428111 |
| 91 | Arthralgia (HP:0002829) | 2.19452788 |
| 92 | Malnutrition (HP:0004395) | 2.16153571 |
| 93 | Osteomyelitis (HP:0002754) | 2.14927417 |
| 94 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.14600141 |
| 95 | Gingival bleeding (HP:0000225) | 2.11340688 |
| 96 | Gangrene (HP:0100758) | 2.11144946 |
| 97 | Vertebral compression fractures (HP:0002953) | 2.10278912 |
| 98 | Asymmetric septal hypertrophy (HP:0001670) | 2.09463509 |
| 99 | Prolonged neonatal jaundice (HP:0006579) | 2.08001534 |
| 100 | Dysostosis multiplex (HP:0000943) | 2.06351098 |
| 101 | Episodic fever (HP:0001954) | 2.04601612 |
| 102 | Progressive visual loss (HP:0000529) | 2.01278171 |
| 103 | Recurrent lower respiratory tract infections (HP:0002783) | 2.00910869 |
| 104 | Hematochezia (HP:0002573) | 1.99447841 |
| 105 | Pulmonary embolism (HP:0002204) | 1.97997991 |
| 106 | Increased CSF protein (HP:0002922) | 1.97275629 |
| 107 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.94758013 |
| 108 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.94758013 |
| 109 | Abnormality of glycolipid metabolism (HP:0010969) | 1.94758013 |
| 110 | Porencephaly (HP:0002132) | 1.92350404 |
| 111 | Steatorrhea (HP:0002570) | 1.91180657 |
| 112 | Peritonitis (HP:0002586) | 1.88456501 |
| 113 | Stenosis of the external auditory canal (HP:0000402) | 1.87602984 |
| 114 | Premature loss of primary teeth (HP:0006323) | 1.87563507 |
| 115 | Pathologic fracture (HP:0002756) | 1.86632715 |
| 116 | Encephalitis (HP:0002383) | 1.85568389 |
| 117 | Alveolar cell carcinoma (HP:0006519) | 1.85233058 |
| 118 | Acne (HP:0001061) | 1.84172251 |
| 119 | Hypergammaglobulinemia (HP:0010702) | 1.83788817 |
| 120 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.82911599 |
| 121 | Hydroxyprolinuria (HP:0003080) | 1.81502394 |
| 122 | Abnormality of proline metabolism (HP:0010907) | 1.81502394 |
| 123 | Xerostomia (HP:0000217) | 1.81227529 |
| 124 | Dementia (HP:0000726) | 1.81159536 |
| 125 | Vertigo (HP:0002321) | 1.80847462 |
| 126 | Memory impairment (HP:0002354) | 1.80740254 |
| 127 | Conjunctival telangiectasia (HP:0000524) | 1.80216301 |
| 128 | Prolonged bleeding time (HP:0003010) | 1.80140785 |
| 129 | Gastrointestinal infarctions (HP:0005244) | 1.80031475 |
| 130 | Abnormality of the nasal septum (HP:0000419) | 1.79993146 |
| 131 | Neoplasm of head and neck (HP:0012288) | 1.78258928 |
| 132 | Esophageal neoplasm (HP:0100751) | 1.78258928 |
| 133 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.77968342 |
| 134 | Peripheral demyelination (HP:0011096) | 1.77719614 |
| 135 | Increased serum ferritin (HP:0003281) | 1.77526385 |
| 136 | Cardiomegaly (HP:0001640) | 1.75816314 |
| 137 | Pigmentary retinal degeneration (HP:0001146) | 1.74531810 |
| 138 | Epistaxis (HP:0000421) | 1.73073022 |
| 139 | Lower limb hyperreflexia (HP:0002395) | 1.71748119 |
| 140 | Polyneuropathy (HP:0001271) | 1.71567896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.79869773 |
| 2 | IRAK3 | 4.35804536 |
| 3 | BLK | 4.33533270 |
| 4 | RIPK4 | 4.30550069 |
| 5 | TBK1 | 4.27977540 |
| 6 | TXK | 4.05459908 |
| 7 | MAP3K3 | 3.20724443 |
| 8 | IRAK4 | 3.00553784 |
| 9 | MAP4K1 | 2.85109189 |
| 10 | ERN1 | 2.76809090 |
| 11 | IKBKB | 2.71053904 |
| 12 | DDR2 | 2.61534844 |
| 13 | IKBKE | 2.57199720 |
| 14 | TAOK1 | 2.54877260 |
| 15 | PBK | 2.54800205 |
| 16 | FGR | 2.43202537 |
| 17 | MAP2K3 | 2.16447649 |
| 18 | TYK2 | 1.96458610 |
| 19 | MAP3K13 | 1.91266912 |
| 20 | CSK | 1.79602233 |
| 21 | ADRBK2 | 1.76720265 |
| 22 | CHUK | 1.67170922 |
| 23 | JAK3 | 1.61925723 |
| 24 | PIM2 | 1.59357759 |
| 25 | BMX | 1.50311372 |
| 26 | ZAP70 | 1.34920077 |
| 27 | PRPF4B | 1.34433379 |
| 28 | GRK7 | 1.34110831 |
| 29 | JAK1 | 1.28371189 |
| 30 | ERBB4 | 1.27143720 |
| 31 | ABL2 | 1.26952021 |
| 32 | LYN | 1.25678387 |
| 33 | KIT | 1.25080096 |
| 34 | MAP3K12 | 1.23918255 |
| 35 | HCK | 1.17481635 |
| 36 | MAPK15 | 1.15224899 |
| 37 | LATS2 | 1.13522845 |
| 38 | SYK | 1.11877946 |
| 39 | CDC42BPA | 1.10153609 |
| 40 | BMPR2 | 1.09448327 |
| 41 | CSF1R | 1.05182599 |
| 42 | STK10 | 1.03123534 |
| 43 | MST1R | 1.02014846 |
| 44 | PIM1 | 1.01775935 |
| 45 | EIF2AK2 | 1.01307932 |
| 46 | MARK3 | 1.01012115 |
| 47 | FES | 0.97360710 |
| 48 | LCK | 0.97188629 |
| 49 | MAP3K5 | 0.87292681 |
| 50 | PDK2 | 0.86156435 |
| 51 | EPHB1 | 0.83982963 |
| 52 | MATK | 0.83911852 |
| 53 | PRKCD | 0.82995859 |
| 54 | ARAF | 0.81396696 |
| 55 | JAK2 | 0.79291192 |
| 56 | YES1 | 0.79140955 |
| 57 | BTK | 0.76663025 |
| 58 | RPS6KA4 | 0.75725693 |
| 59 | ABL1 | 0.73878600 |
| 60 | IRAK2 | 0.70223337 |
| 61 | CAMKK2 | 0.68486245 |
| 62 | SIK2 | 0.68130869 |
| 63 | MST4 | 0.68091488 |
| 64 | EGFR | 0.63001827 |
| 65 | SIK3 | 0.60859587 |
| 66 | TAOK3 | 0.59601572 |
| 67 | MUSK | 0.59030302 |
| 68 | MAP2K6 | 0.58847192 |
| 69 | DAPK3 | 0.57579048 |
| 70 | MAP3K11 | 0.56888888 |
| 71 | NEK9 | 0.55430870 |
| 72 | ADRBK1 | 0.54136086 |
| 73 | CLK1 | 0.53678209 |
| 74 | STK24 | 0.53434952 |
| 75 | TYRO3 | 0.52777771 |
| 76 | LRRK2 | 0.52637893 |
| 77 | FYN | 0.50808802 |
| 78 | PDGFRA | 0.49235605 |
| 79 | DYRK3 | 0.45625780 |
| 80 | BMPR1B | 0.44917764 |
| 81 | RIPK1 | 0.43568908 |
| 82 | PAK4 | 0.43296629 |
| 83 | TEC | 0.43181182 |
| 84 | PDGFRB | 0.42466716 |
| 85 | TAOK2 | 0.42355260 |
| 86 | TGFBR2 | 0.41384640 |
| 87 | IRAK1 | 0.40085318 |
| 88 | DAPK2 | 0.40080435 |
| 89 | TTN | 0.39580672 |
| 90 | EPHA3 | 0.39212249 |
| 91 | MAPK7 | 0.38611544 |
| 92 | GSK3A | 0.38026030 |
| 93 | NUAK1 | 0.36841266 |
| 94 | PRKG2 | 0.33996966 |
| 95 | SIK1 | 0.33535171 |
| 96 | MAP3K1 | 0.32950429 |
| 97 | EIF2AK3 | 0.32688669 |
| 98 | NME2 | 0.32109281 |
| 99 | ACVR1B | 0.31689007 |
| 100 | PTK6 | 0.31017504 |
| 101 | MAPKAPK2 | 0.30680711 |
| 102 | INSR | 0.30469904 |
| 103 | STK4 | 0.29385792 |
| 104 | RPS6KC1 | 0.27920912 |
| 105 | RPS6KL1 | 0.27920912 |
| 106 | MAP3K10 | 0.27284162 |
| 107 | PRKCQ | 0.27269859 |
| 108 | CDK6 | 0.26711732 |
| 109 | STK3 | 0.26150661 |
| 110 | TESK1 | 0.25619890 |
| 111 | CAMK1D | 0.23908365 |
| 112 | TRPM7 | 0.23429169 |
| 113 | MOS | 0.22729363 |
| 114 | RPS6KA1 | 0.22474031 |
| 115 | PKN1 | 0.22368210 |
| 116 | ERBB3 | 0.21933233 |
| 117 | IGF1R | 0.21636773 |
| 118 | HIPK2 | 0.21262353 |
| 119 | PRKCH | 0.20193789 |
| 120 | PLK2 | 0.19792886 |
| 121 | KSR2 | 0.19257799 |
| 122 | ITK | 0.18897306 |
| 123 | PDPK1 | 0.18591301 |
| 124 | MAPK4 | 0.18105792 |
| 125 | MAP3K9 | 0.17534664 |
| 126 | PRKCE | 0.16540793 |
| 127 | LMTK2 | 0.15636439 |
| 128 | TESK2 | 0.15006343 |
| 129 | PDK1 | 0.14256934 |
| 130 | RPS6KA6 | 0.14211298 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 5.37205550 |
| 2 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.69977976 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.57910110 |
| 4 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 3.28844784 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 3.18748026 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.06248081 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.88405706 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.81678037 |
| 9 | * Legionellosis_Homo sapiens_hsa05134 | 2.79792384 |
| 10 | Pertussis_Homo sapiens_hsa05133 | 2.74989247 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.71370351 |
| 12 | Malaria_Homo sapiens_hsa05144 | 2.67059427 |
| 13 | Asthma_Homo sapiens_hsa05310 | 2.55191574 |
| 14 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.54996725 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 2.43968647 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.38025093 |
| 17 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.37357816 |
| 18 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.18442083 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.16718639 |
| 20 | * Salmonella infection_Homo sapiens_hsa05132 | 2.05963922 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.96653332 |
| 22 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.92548333 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.74964005 |
| 24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.67447648 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.61310592 |
| 26 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.58427306 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.36242938 |
| 28 | Amoebiasis_Homo sapiens_hsa05146 | 1.28215230 |
| 29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.27065689 |
| 30 | Prion diseases_Homo sapiens_hsa05020 | 1.26027719 |
| 31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.25119274 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.24850726 |
| 33 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.22454003 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.21424527 |
| 35 | Bladder cancer_Homo sapiens_hsa05219 | 1.15550789 |
| 36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.08899683 |
| 37 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08878785 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.08238467 |
| 39 | Lysosome_Homo sapiens_hsa04142 | 1.07496254 |
| 40 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.01047924 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 0.95530715 |
| 42 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92034788 |
| 43 | Hepatitis C_Homo sapiens_hsa05160 | 0.90610972 |
| 44 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.84567660 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 0.81650324 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 0.80360513 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.74048037 |
| 48 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.73424927 |
| 49 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.71346714 |
| 50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.70519107 |
| 51 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.65348708 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 0.63206401 |
| 53 | Mineral absorption_Homo sapiens_hsa04978 | 0.60493941 |
| 54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.59756498 |
| 55 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58351091 |
| 56 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57214805 |
| 57 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54523142 |
| 58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53387603 |
| 59 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.51578179 |
| 60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51347797 |
| 61 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.46036382 |
| 62 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45045461 |
| 63 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43235343 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.41655338 |
| 65 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40325727 |
| 66 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.38481852 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36901812 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.35420965 |
| 69 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.34114032 |
| 70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31252000 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.29128883 |
| 72 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.28990396 |
| 73 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.28809922 |
| 74 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.26832633 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26478676 |
| 76 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.25303802 |
| 77 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.24695090 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24413071 |
| 79 | Platelet activation_Homo sapiens_hsa04611 | 0.23578790 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22001454 |
| 81 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.20420409 |
| 82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.19337805 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.19270751 |
| 84 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.18864846 |
| 85 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.18195820 |
| 86 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.17888399 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.17132170 |
| 88 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.17032626 |
| 89 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.15725581 |
| 90 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.15407321 |
| 91 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.11809575 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.11787713 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.11189201 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.10961728 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.10767349 |
| 96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.10408669 |
| 97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.09449919 |
| 98 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.09314123 |
| 99 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.08054615 |
| 100 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.07735227 |
| 101 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.07673032 |
| 102 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.06594363 |
| 103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.05764592 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.04259310 |
| 105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.04237946 |
| 106 | HTLV-I infection_Homo sapiens_hsa05166 | 0.04053362 |
| 107 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.02142490 |
| 108 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.01663144 |
| 109 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | -0.0410772 |
| 110 | Caffeine metabolism_Homo sapiens_hsa00232 | -0.0376261 |
| 111 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | -0.0353972 |
| 112 | Notch signaling pathway_Homo sapiens_hsa04330 | -0.0251799 |
| 113 | MicroRNAs in cancer_Homo sapiens_hsa05206 | -0.0200076 |
| 114 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0161594 |
| 115 | Viral carcinogenesis_Homo sapiens_hsa05203 | -0.0087697 |

